EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Organogermanium THGP Induces Differentiation into M1 Macrophages and Suppresses the Proliferation of Melanoma Cells via Phagocytosis

Junya Azumi iD, Tomoya Takeda, Yasuhiro Shimada, Tao Zhuang iD, Yoshihiko Tokuji iD, Naoya Sakamoto, Hisashi Aso, Takashi Nakamura iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24031885 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Junya Azumi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Division, Asai Germanium Research Institute Co., Ltd., Suzuranoka 3-131, Hakodate 042-0958, Japan. Hauptthemen laut MEDLINE: Macrophages, Melanoma, Experimental. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Asai Germanium Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

M1 macrophages are an important cell type related to tumor immunology and are known to phagocytose cancer cells. In previous studies, the organogermanium compound poly-trans-[(2-carboxyethyl)germasesquioxane] (Ge-132) and its hydrolysate, 3-(trihydroxygermyl) propanoic acid (THGP), have been reported to exert antitumor effects by activating NK cells and macrophages through the induction of IFN-γ activity in vivo. However, the detailed molecular mechanism has not been clarified. In this study, we found that macrophages differentiate into the M1 phenotype via NF-κB activation under long-term culture in the presence of THGP in vitro and in vivo. Furthermore, long-term culture with THGP increases the ability of RAW 264.7 cells to suppress B16 4A5 melanoma cell proliferation. These mechanisms indicate that THGP promotes the M1 polarization of macrophages and suppresses the expression of signal-regulatory protein alpha (SIRP-α) in macrophages and CD47 in cancers. Based on these results, THGP may be considered a new regulatory reagent that suppresses tumor immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesMelanoma, ExperimentalMiceAnimalsPhagocytosisCell DifferentiationRAW 264.7 Cells

Stichwörter der Autor:innen

Ge-132M1 macrophageTHGPmelanomaorganogermanium

Autor:innen und Institutionen

  • Research Division, Asai Germanium Research Institute Co., Ltd., Suzuranoka 3-131, Hakodate 042-0958, Japan.
  • Laboratory of Animal Health Science, Graduate School of Agricultural Science, Tohoku University, 468-1 Aoba, Aramaki, Aoba-ku, Sendai 980-8572, Japan.
  • Department of Human Sciences, Obihiro University of Agriculture and Veterinary Medicine, Nishi 2 Sen, Inada, Obihiro 080-8555, Japan.
  • Isotope Imaging Laboratory, Creative Research Institution, Hokkaido University, Kita 10 Jo-Nishi 5, Kita, Sapporo 060-0810, Japan.

ORCID-Profile: Junya Azumi, Tao Zhuang, Yoshihiko Tokuji, Takashi Nakamura

Förderung

  • Asai Germanium Research Institute

Zitieren

APA

Azumi, J., Takeda, T., Shimada, Y., Zhuang, T., Tokuji, Y., Sakamoto, N., Aso, H., & Nakamura, T. (2023). Organogermanium THGP Induces Differentiation into M1 Macrophages and Suppresses the Proliferation of Melanoma Cells via Phagocytosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24031885

Vancouver

Azumi J, Takeda T, Shimada Y, Zhuang T, Tokuji Y, Sakamoto N, et al. Organogermanium THGP Induces Differentiation into M1 Macrophages and Suppresses the Proliferation of Melanoma Cells via Phagocytosis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24031885

BibTeX
@article{Azumi2023,
  author = {Azumi, Junya and Takeda, Tomoya and Shimada, Yasuhiro and Zhuang, Tao and Tokuji, Yoshihiko and Sakamoto, Naoya and Aso, Hisashi and Nakamura, Takashi},
  title = {Organogermanium THGP Induces Differentiation into M1 Macrophages and Suppresses the Proliferation of Melanoma Cells via Phagocytosis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24031885}
}
Kostenlos starten →